Free Trial
TSE:EVGN

Evogene (EVGN) Stock Price, News & Analysis

Evogene logo

About Evogene Stock (TSE:EVGN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.00
Consensus Rating
Buy

Company Overview

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.

Receive EVGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter.

EVGN Stock News Headlines

ICL acquires Evogene subsidiary Lavie Bio
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts.
Q4 2024 Evogene Ltd Earnings Call Transcript
See More Headlines

EVGN Stock Analysis - Frequently Asked Questions

Shares of EVGN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evogene investors own include Acacia Communications (ACIA), Hyliion (HYLN), Purple Biotech (PPBT), Viper Networks (VPER), Butterfly Network (BFLY), Alibaba Group (BABA) and AquaBounty Technologies (AQB).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Pesticide & Other Agricultural Chemical Manufacturing
Sub-Industry
Chemicals
Current Symbol
TSE:EVGN
CIK
N/A
Fax
N/A
Employees
140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$3.00
High Stock Price Target
C$3.00
Low Stock Price Target
C$3.00
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (TSE:EVGN) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners